Literature DB >> 22842596

The Less Drugs Regimens (LDRs) therapy approach in HIV-1: an Italian expert panel perspective for the long-term management of HIV-1 infection.

Simone Marcotullio, Massimo Andreoni, Andrea Antinori, Antonella d'Arminio Monforte, Giovanni Di Perri, Massimo Galli, Giuseppe Ippolito, Carlo Federico Perno, Giuliano Rizzardini, Adriano Lazzarin, Paola Cinque, Guerino Fares, Emanuela Foglia, Cristina Gervasoni, Rita Murri, Silvia Nozza, Stefano Rusconi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22842596

Source DB:  PubMed          Journal:  New Microbiol        ISSN： 1121-7138            Impact factor:   2.479


× No keyword cloud information.
  4 in total

1.  Darunavir-based dual therapy of treatment-experienced HIV-infected patients: analysis from a national multicenter database.

Authors:  Gaetana Sterrantino; Mauro Zaccarelli; Antonio Di Biagio; Maria Luisa Biondi; Andrea Antinori; Giovanni Penco
Journal:  Infection       Date:  2015-03-28       Impact factor: 3.553

Review 2.  Ageing with HIV: a multidisciplinary review.

Authors:  A Calcagno; S Nozza; C Muss; B M Celesia; F Carli; S Piconi; G V De Socio; A M Cattelan; G Orofino; D Ripamonti; A Riva; G Di Perri
Journal:  Infection       Date:  2015-05-19       Impact factor: 3.553

3.  Coconut Oil Extract Mitigates Testicular Injury Following Adjuvant Treatment with Antiretroviral Drugs.

Authors:  Oluwatosin O Ogedengbe; Ayoola I Jegede; Ismail O Onanuga; Ugochukwu Offor; Edwin Cs Naidu; Aniekan I Peter; Onyemaechi O Azu
Journal:  Toxicol Res       Date:  2016-10-30

4.  Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter observational study.

Authors:  Alessandra Latini; Massimiliano Fabbiani; Vanni Borghi; Gaetana Sterrantino; Alberto Giannetti; Patrizia Lorenzini; Laura Loiacono; Adriana Ammassari; Rita Bellagamba; Manuela Colafigli; Gabriella D'Ettorre; Simona Di Giambenedetto; Andrea Antinori; Mauro Zaccarelli
Journal:  BMC Infect Dis       Date:  2016-08-11       Impact factor: 3.090
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.